0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Hit and Lead Profiling - Identification and Optimization of Drug-like Molecules (Hardcover) Loot Price: R3,653
Discovery Miles 36 530
You Save: R904 (20%)
Hit and Lead Profiling - Identification and Optimization of Drug-like Molecules (Hardcover): Bernard Faller, Laszlo Urban

Hit and Lead Profiling - Identification and Optimization of Drug-like Molecules (Hardcover)

Bernard Faller, Laszlo Urban; Series edited by Raimund Mannhold, Hugo Kubinyi, Gerd Folkers

Series: Methods and Principles in Medicinal Chemistry

 (sign in to rate)
List price R4,557 Loot Price R3,653 Discovery Miles 36 530 | Repayment Terms: R339 pm x 12* You Save R904 (20%)

Bookmark and Share

Expected to ship within 7 - 12 working days

The only reference on current methods to generate pharmacokinetic and safety profiles of drug candidates, as well as how they must be balanced against one other for the best selection of candidates for further development.
Following a brief introduction to the necessities of filtering and risk assessment of potential new drug molecules before actual drug development, the two equally important aspects of pharmacological (ADME) and safety (toxicity) profiling are covered in separate parts.
The ADME section covers the profiling of basic physicochemical parameters, such as solubility and permeability, as well as more complex traits, such as the likelihood of drug-drug interactions, metabolic clearance and protein binding properties.
The toxicology part addresses, among others, recent advances in early genetic toxicity testing, bioactivation screening, organ-specific toxicity assays for liver, heart, kidney and blood, as well as profiling for autoimmune reactions.
By addressing both drug efficiency and drug safety, this modern practical reference shows readers how each individual aspect figures in shaping the key decisions on which the entire drug development process hinges. In short, this is a complete toolbox for assessing the risk/benefit ratio for any novel compound during the early drug development stages, using both in vitro and in silico methods.
Both editors are based at one of the leading research-driven pharmaceutical companies, and the authors have been recruited from numerous other global players in the field.
Invaluable know-how for every medicinal chemist and drug developer.

General

Imprint: Wiley-VCH Verlag GmbH
Country of origin: Germany
Series: Methods and Principles in Medicinal Chemistry
Release date: August 2009
First published: September 2009
Editors: Bernard Faller • Laszlo Urban
Series editors: Raimund Mannhold • Hugo Kubinyi • Gerd Folkers
Dimensions: 241 x 175 x 31mm (L x W x T)
Format: Hardcover
Pages: 533
ISBN-13: 978-3-527-32331-9
Categories: Books > Professional & Technical > Industrial chemistry & manufacturing technologies
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Promotions
LSN: 3-527-32331-7
Barcode: 9783527323319

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners